KaloBios Close To $10M Financing After Drug Rights Buy
Pharmaceutical company KaloBios said Friday it has reached a tentative agreement on $10 million in bankruptcy financing as a result of its approved purchase of the licensing and regulatory rights to...To view the full article, register now.
Already a subscriber? Click here to view full article